Type 2 diabetes treatment approved for children and adolescents
18 June 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.
List view / Grid view
Big Pharma
US-China trade war leaves gap for Indian pharma to grow
18 June 2019 | By Victoria Rees (European Pharmaceutical Review)
A data analyst has reported that the current US-China trade war will give India chance to increase their pharmaceutical presence.
Amyloidosis treatment discontinued from clinical trials
10 June 2019 | By European Pharmaceutical Review
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
Ten big pharma companies collaborate on data sharing AI
7 June 2019 | By Victoria Rees (European Pharmaceutical Review)
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
Proposed biosimilar accepted for review by EMA
3 June 2019 | By Victoria Rees (European Pharmaceutical Review)
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
Shingles vaccine approved for use in China
3 June 2019 | By Victoria Rees (European Pharmaceutical Review)
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.
FDA approves first gene therapy for paediatric spinal muscular atrophy
29 May 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
Four drug companies accused of illegal market sharing
24 May 2019 | By Victoria Rees (European Pharmaceutical Review)
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
Mirikizimab moved to Phase III after positive trial findings
23 May 2019 | By Victoria Rees (European Pharmaceutical Review)
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
GSK and Novartis ‘misled’ consumers, says Federal Court of Australia
20 May 2019 | By Victoria Rees (European Pharmaceutical Review)
GSK and Novartis found to have misled consumers with the packaging and pricing of their osteoarthritis pain treatment.
US drugmakers allegedly collude on generic price hikes
14 May 2019 | By European Pharmaceutical Review
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
Strong line-up for Chemspec Europe 2019
10 May 2019 | By Chemspec Europe 2019
Chemspec Europe 2019 gathers impressive array of industry experts under one roof
Haseeb Ahmad has been named as the new president of ABPI
8 May 2019 | By European Pharmaceutical Review
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
Is the pharma sector ready for a ‘no-deal’ Brexit?
25 April 2019 | By Nikki Withers (European Pharmaceutical Review)
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
Europe-Africa partnership spearheads development of next-generation antimalarial drug
18 April 2019 | By Nikki Withers (European Pharmaceutical Review)
The grant will support African trials of a novel antimalarial combination comprising KAF156 (ganaplacide) and lumefantrine in a new once-daily formulation...
Follow: